• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.69% Nasdaq Up2.12%

    Catalyst Pharmaceutical Partners Inc. (CPRX)

    -NasdaqCM
    2.88 0.01(0.17%) Dec 17, 4:00PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.0
    Mean Recommendation (last week):2.0
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:7.00
    Median Target:6.00
    High Target:13.00
    Low Target:4.00
    No. of Brokers:5

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 24, 2013Maxim GroupInitiated Buy
    Apr 18, 2013Aegis CapitalInitiated Buy
    Aug 27, 2012Rodman & RenshawUpgradeMkt PerformMkt Outperform
    Oct 1, 2009MerrimanUpgradeSellNeutral
    May 29, 2009Merriman Curhan FordDowngradeBuySell
    May 29, 2009HapoalimDowngradeNeutralUnderperform
    Dec 15, 2008Merriman Curhan FordInitiated Buy
    Nov 28, 2007Rodman & RenshawInitiated Mkt Outperform
    Jan 31, 2007Stifel NicolausInitiated Buy
    Jan 5, 2007First AlbanyInitiated Buy
    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0000
    Buy5544
    Hold0000
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.